Life Science Investing Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Life Science Investing Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Life Science Investing Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis Program
Life Science Investing Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
SAGA Metals Completes Phase 2 of Major Drill Program at the Radar Project in Labrador-Confirms Extensive Oxide Mineralization in All Drill Locations at Trapper North and South Zones & Provides Corporate Update
